These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 37496051)

  • 1. A traditional gynecological medicine inhibits ovarian cancer progression and eliminates cancer stem cells via the LRPPRC-OXPHOS axis.
    Jiang R; Chen Z; Ni M; Li X; Ying H; Fen J; Wan D; Peng C; Zhou W; Gu L
    J Transl Med; 2023 Jul; 21(1):504. PubMed ID: 37496051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platinum-induced mitochondrial OXPHOS contributes to cancer stem cell enrichment in ovarian cancer.
    Sriramkumar S; Sood R; Huntington TD; Ghobashi AH; Vuong TT; Metcalfe TX; Wang W; Nephew KP; O'Hagan HM
    J Transl Med; 2022 May; 20(1):246. PubMed ID: 35641987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gossypol acetic acid regulates leukemia stem cells by degrading LRPPRC
    Ai CJ; Chen LJ; Guo LX; Wang YP; Zhao ZY
    World J Stem Cells; 2024 Apr; 16(4):444-458. PubMed ID: 38690512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting PUF60 prevents tumor progression by retarding mRNA decay of oxidative phosphorylation in ovarian cancer.
    Zhang C; Ni X; Tao C; Zhou Z; Wang F; Gu F; Cui X; Jiang S; Li Q; Lu H; Li D; Wu Z; Zhang R
    Cell Oncol (Dordr); 2024 Feb; 47(1):157-174. PubMed ID: 37632669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the miR-34a/LRPPRC/MDR1 axis collapse the chemoresistance in P53 inactive colorectal cancer.
    Yang Y; Yuan H; Zhao L; Guo S; Hu S; Tian M; Nie Y; Yu J; Zhou C; Niu J; Wang G; Song Y
    Cell Death Differ; 2022 Nov; 29(11):2177-2189. PubMed ID: 35484333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LRPPRC regulates malignant behaviors, protects mitochondrial homeostasis, mitochondrial function in osteosarcoma and derived cancer stem-like cells.
    Zhao Z; Sun Y; Tang J; Yang Y; Xu X
    BMC Cancer; 2023 Oct; 23(1):935. PubMed ID: 37789316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The RNA-binding protein LRPPRC promotes resistance to CDK4/6 inhibition in lung cancer.
    Zhou W; Wang W; Liang Y; Jiang R; Qiu F; Shao X; Liu Y; Fang L; Ni M; Yu C; Zhao Y; Huang W; Li J; Donovan MJ; Wang L; Ni J; Wang D; Fu T; Feng J; Wang X; Tan W; Fang X
    Nat Commun; 2023 Jul; 14(1):4212. PubMed ID: 37452037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-23a depletion promotes apoptosis of ovarian cancer stem cell and inhibits cell migration by targeting DLG2.
    Zhuang RJ; Bai XX; Liu W
    Cancer Biol Ther; 2019; 20(6):897-911. PubMed ID: 30862230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of hepatic LRPPRC alters mitochondrial bioenergetics, regulation of permeability transition and trans-membrane ROS diffusion.
    Cuillerier A; Honarmand S; Cadete VJJ; Ruiz M; Forest A; Deschênes S; Beauchamp C; ; Charron G; Rioux JD; Des Rosiers C; Shoubridge EA; Burelle Y
    Hum Mol Genet; 2017 Aug; 26(16):3186-3201. PubMed ID: 28575497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MARCH5 promotes aerobic glycolysis to facilitate ovarian cancer progression via ubiquitinating MPC1.
    Xu Y; Zhao S; Shen Y; Li Y; Dang Y; Guo F; Chen Z; Li J; Yang H
    Apoptosis; 2024 Aug; 29(7-8):1232-1245. PubMed ID: 38615083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasome-Independent Protein Knockdown by Small-Molecule Inhibitor for the Undruggable Lung Adenocarcinoma.
    Zhou W; Sun G; Zhang Z; Zhao L; Xu L; Yuan H; Li S; Dong Z; Song Y; Fang X
    J Am Chem Soc; 2019 Nov; 141(46):18492-18499. PubMed ID: 31657561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of leucine-rich pentatricopeptide repeat motif-containing protein (LRPPRC) for anti-apoptosis and tumourigenesis in cancers.
    Tian T; Ikeda J; Wang Y; Mamat S; Luo W; Aozasa K; Morii E
    Eur J Cancer; 2012 Oct; 48(15):2462-73. PubMed ID: 22326293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MS4A15 acts as an oncogene in ovarian cancer through reprogramming energy metabolism.
    Fang Y; Yu H; Zhou H
    Biochem Biophys Res Commun; 2022 Apr; 598():47-54. PubMed ID: 35151203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LRPPRC promotes glycolysis by stabilising LDHA mRNA and its knockdown plus glutamine inhibitor induces synthetic lethality via m
    Yu Y; Deng H; Wang W; Xiao S; Zheng R; Lv L; Wang H; Chen J; Zhang B
    Clin Transl Med; 2024 Feb; 14(2):e1583. PubMed ID: 38372449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. F-Box and Leucine-Rich Repeat Protein 20 (FBXL20), Negatively Regulated by microRNA (miR)-195-5p, Accelerates the Malignant Progression of Ovarian Cancer.
    Wu D; Liu C; Hong L
    Mol Biotechnol; 2021 Dec; 63(12):1235-1243. PubMed ID: 34338995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Hepatic Fatty Acids Uptake and Oxidation by LRPPRC-Driven Oxidative Phosphorylation Reduces Blood Lipid Levels.
    Lei S; Sun RZ; Wang D; Gong MZ; Su XP; Yi F; Peng ZW
    Front Physiol; 2016; 7():270. PubMed ID: 27462273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of LRPPRC induces apoptosis in prostate cancer cells through the mitochondria-mediated pathway.
    Zhou J; Zhang F; Hou X; Zhang N
    Cancer Biother Radiopharm; 2014 Nov; 29(9):345-50. PubMed ID: 25379610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of CXCL12-CXCR4 axis in ovarian cancer metastasis and CXCL12-CXCR4 blockade with AMD3100 suppresses tumor cell migration and invasion in vitro.
    Liu Y; Ren CC; Yang L; Xu YM; Chen YN
    J Cell Physiol; 2019 Apr; 234(4):3897-3909. PubMed ID: 30191987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated transcriptomic and proteomic analysis reveals Guizhi-Fuling Wan inhibiting STAT3-EMT in ovarian cancer progression.
    Ma Q; Chen F; Liu Y; Wu K; Bu Z; Qiu C; Neamati N; Lu T
    Biomed Pharmacother; 2024 Jan; 170():116016. PubMed ID: 38128180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
    Hao T; Huang S; Han F
    Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.